Radiotherapy firm BrainLab reported the first treatment of a liver tumor patient with its new tumor tracking and targeting system, ExacTrac X-Ray Adaptive Gating. The patient was treated at the AZ-VUB in Brussels, Belgium, by the team of Dr. Guy Storme.
The product enhances the firm's system for the treatment of lung and liver tumors with gating, which allows physicians to address tumor movement caused by the patient's breathing, according to Munich-based BrainLab. The gating feature allows the radiation beam to be synchronized with the patient's breathing frequency, and to irradiate the tumor when it is located exactly in the path of the beam.
The ExacTrac's infrared tracking technology enables automatic, multiple x-ray image acquisition during the patient's breathing cycle. These x-ray image sets allow the detection of the tumor's three-dimensional movement in relation to a previously implanted marker. The exact magnitude of tumor movement is calculated automatically in 3D, allowing precise synchronization of the beam-on window with the patient's breathing frequency, according to BrainLab.
By AuntMinnie.com staff writers
September 29, 2004
Related Reading
BrainLab, Axeda partner, July 12, 2004
BrainLab sells 50th Novalis system, May 4, 2004
BrainLab places Novalis at John Muir, March 23, 2004
BrainLab installs first U.S. VectorVision sky site, March 10, 2004
BrainLab wins ruling in Nomos patent lawsuit, February 10, 2004
Copyright © 2004 AuntMinnie.com
